Precocious neuronal differentiation and disrupted oxygen responses in Kabuki syndrome.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsCarosso, Giovanni A
Augustin, Jonathan J
Nguyen, Ha Nam
Winer, Briana L
Cannon, Gabrielle H
Robertson, Johanna D
Hansen, Kasper D
Goff, Loyal A
Bjornsson, Hans T
MetadataShow full item record
CitationCarosso GA, Boukas L, Augustin JJ, Nguyen HN, Winer BL, Cannon GH, Robertson JD, Zhang L, Hansen KD, Goff LA, Bjornsson HT. Precocious neuronal differentiation and disrupted oxygen responses in Kabuki syndrome. JCI Insight. 2019 Oct 17;4(20):e129375. doi: 10.1172/jci.insight.129375.
AbstractChromatin modifiers act to coordinate gene expression changes critical to neuronal differentiation from neural stem/progenitor cells (NSPCs). Lysine-specific methyltransferase 2D (KMT2D) encodes a histone methyltransferase that promotes transcriptional activation and is frequently mutated in cancers and in the majority (>70%) of patients diagnosed with the congenital, multisystem intellectual disability disorder Kabuki syndrome 1 (KS1). Critical roles for KMT2D are established in various non-neural tissues, but the effects of KMT2D loss in brain cell development have not been described. We conducted parallel studies of proliferation, differentiation, transcription, and chromatin profiling in KMT2D-deficient human and mouse models to define KMT2D-regulated functions in neurodevelopmental contexts, including adult-born hippocampal NSPCs in vivo and in vitro. We report cell-autonomous defects in proliferation, cell cycle, and survival, accompanied by early NSPC maturation in several KMT2D-deficient model systems. Transcriptional suppression in KMT2D-deficient cells indicated strong perturbation of hypoxia-responsive metabolism pathways. Functional experiments confirmed abnormalities of cellular hypoxia responses in KMT2D-deficient neural cells and accelerated NSPC maturation in vivo. Together, our findings support a model in which loss of KMT2D function suppresses expression of oxygen-responsive gene programs important to neural progenitor maintenance, resulting in precocious neuronal differentiation in a mouse model of KS1.
DescriptionTo access publisher's full text version of this article click on the hyperlink below
- The histone methyltransferase KMT2D, mutated in Kabuki syndrome patients, is required for neural crest cell formation and migration.
- Authors: Schwenty-Lara J, Nehl D, Borchers A
- Issue date: 2020 Jan 15
- Precocious chondrocyte differentiation disrupts skeletal growth in Kabuki syndrome mice.
- Authors: Fahrner JA, Lin WY, Riddle RC, Boukas L, DeLeon VB, Chopra S, Lad SE, Luperchio TR, Hansen KD, Bjornsson HT
- Issue date: 2019 Oct 17
- The KMT2D Kabuki syndrome histone methylase controls neural crest cell differentiation and facial morphology.
- Authors: Shpargel KB, Mangini CL, Xie G, Ge K, Magnuson T
- Issue date: 2020 Jul 17
- Loss of function of Kmt2d, a gene mutated in Kabuki syndrome, affects heart development in Xenopus laevis.
- Authors: Schwenty-Lara J, Nürnberger A, Borchers A
- Issue date: 2019 Jun
- Histone H3 lysine 4 methyltransferase KMT2D.
- Authors: Froimchuk E, Jang Y, Ge K
- Issue date: 2017 Sep 5